Literature DB >> 8294435

Functional domains of recombinant bactericidal/permeability increasing protein (rBPI23).

R G Little1, D N Kelner, E Lim, D J Burke, P J Conlon.   

Abstract

The 23-kDa recombinant amino-terminal bactericidal/permeability increasing protein fragment (rBPI23) has all of the antibacterial and antiendotoxin properties of the holoprotein. In the current studies, we have identified multiple active domains within rBPI23 with chemical and proteolytic cleavage fragments and with synthetic overlapping peptides. We also demonstrate a novel, high affinity heparin binding property for rBPI23, in addition to its established bactericidal and lipopolysaccharide binding properties. Cleavage fragments and synthetic, overlapping peptides of rBPI23 were analyzed for inhibition of the lipopolysaccharide-induced Limulus amebocyte lysate reaction, for bactericidal activity, and for heparin binding. Three separate, active domains were identified in amino acid regions 17-45, 65-99, and 142-169. A single synthetic peptide (85-99) was bactericidal. These results indicate that rBPI23 is comprised of three separate functional domains which contribute to the high affinity interaction of rBPI23 with Gram-negative bacteria. The individual activity of each domain and the cooperative interaction among domains provide the basis for developing rBPI23 analogues with increased biologic efficacy.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8294435

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  29 in total

1.  Apolipoprotein CI enhances the biological response to LPS via the CD14/TLR4 pathway by LPS-binding elements in both its N- and C-terminal helix.

Authors:  Jimmy F P Berbée; Claudia P Coomans; Marit Westerterp; Johannes A Romijn; Louis M Havekes; Patrick C N Rensen
Journal:  J Lipid Res       Date:  2010-03-24       Impact factor: 5.922

2.  Identification and characterization of the antimicrobial peptide corresponding to C-terminal beta-sheet domain of tenecin 1, an antibacterial protein of larvae of Tenebrio molitor.

Authors:  K H Lee; S Y Hong; J E Oh; M Kwon; J H Yoon; J Lee; B L Lee; H M Moon
Journal:  Biochem J       Date:  1998-08-15       Impact factor: 3.857

3.  Interaction of NK lysin, a peptide produced by cytolytic lymphocytes, with endotoxin.

Authors:  M Andersson; R Girard; P Cazenave
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

4.  The role of liver and kidney on the pharmacokinetics of a recombinant amino terminal fragment of bactericidal/permeability-increasing protein in rats.

Authors:  R J Bauer; K Der; N Ottah-Ihejeto; J Barrientos; A H Kung
Journal:  Pharm Res       Date:  1997-02       Impact factor: 4.200

5.  The BPI/LBP family of proteins: a structural analysis of conserved regions.

Authors:  L J Beamer; S F Carroll; D Eisenberg
Journal:  Protein Sci       Date:  1998-04       Impact factor: 6.725

6.  N-linked glycosylation at Asn3 and the positively charged residues within the amino-terminal domain of the c1 inhibitor are required for interaction of the C1 Inhibitor with Salmonella enterica serovar typhimurium lipopolysaccharide and lipid A.

Authors:  Dongxu Liu; Cort C Cramer; Jennifer Scafidi; Alvin E Davis
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

7.  A rabbit vaginal cell-derived antimicrobial peptide, RVFHbαP, blocks lipopolysaccharide-mediated inflammation in human vaginal cells in vitro.

Authors:  Mandar S Patgaonkar; Ameya Sathe; C Selvaakumar; K V R Reddy
Journal:  Clin Vaccine Immunol       Date:  2011-08-24

8.  Effect of anticoagulants on binding and neutralization of lipopolysaccharide by the peptide immunoglobulin conjugate CAP18(106-138)-immunoglobulin G in whole blood.

Authors:  M Ogata; M F Fletcher; M Kloczewiak; P M Loiselle; E M Zanzot; M W Vermeulen; H S Warren
Journal:  Infect Immun       Date:  1997-06       Impact factor: 3.441

9.  Group of peptides that act synergistically with hydrophobic antibiotics against gram-negative enteric bacteria.

Authors:  M Vaara; M Porro
Journal:  Antimicrob Agents Chemother       Date:  1996-08       Impact factor: 5.191

10.  BPI-ANCA in transporter associated with antigen presentation (TAP) deficiency: possible role in susceptibility to Gram-negative bacterial infections.

Authors:  H Schultz; S Schinke; J Weiss; V Cerundolo; W L Gross; S Gadola
Journal:  Clin Exp Immunol       Date:  2003-08       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.